• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于保护性胸膜肺炎放线杆菌亚单位疫苗的新策略:通过铁限制诱导培养物的去污剂提取

A novel strategy for protective Actinobacillus pleuropneumoniae subunit vaccines: detergent extraction of cultures induced by iron restriction.

作者信息

Goethe R, Gonzáles O F, Lindner T, Gerlach G F

机构信息

Institut für Mikrobiologie und Tierseuchen, Tieraerztliche Hochschule Hannover, Bischofsholer Damm 15, 30173, Hannover, Germany.

出版信息

Vaccine. 2000 Nov 22;19(7-8):966-75. doi: 10.1016/s0264-410x(00)00212-7.

DOI:10.1016/s0264-410x(00)00212-7
PMID:11115723
Abstract

We have characterized antigens from Actinobacillus (A.) pleuropneumoniae grown under iron restriction with respect to their immunogenic and protective potential. Antigens were the cell-free culture supernatants (CFS) obtained after treatment of A. pleuropneumoniae broth cultures with sodium deoxycholate. Using the iron-repressible transferrin-binding lipoprotein TbpB and the constitutively expressed outer membrane lipoprotein OmlA as markers, we have shown that the detergent extraction enriched the CFS with lipoproteins from the outer membrane (OM). Extractions with 0.05% of sodium deoxycholate increased the lipoprotein contents in the CFS, but did not affect the integrity of the OM. This was demonstrated by the absence of the iron-repressible integral OM transferrin-binding protein TbpA. Furthermore, the absence of periplasmic and cytoplasmic proteins in CFS after extraction was determined in immunoblot analyses with anti-bacterial alkaline phosphatase and anti-Hsp60 antisera, demonstrating that there was no rupture of the OMs or the plasma membranes due to the extraction procedure. Antigen preparations from A. pleuropneumoniae serotype 2 and 9 grown under iron restrictive conditions were combined, emulsified, and tested for their ability to confer protection in pigs. Pigs immunized with CFS from sodium deoxycholate extracted cultures developed a strong antibody response and, upon challenge with A. pleuropneumoniae serotype 2, the immunized pigs showed no or only mild clinical signs of disease and had a significantly lower degree of lung damage than the control pigs.

摘要

我们已对胸膜肺炎放线杆菌在铁限制条件下生长的抗原的免疫原性和保护潜力进行了表征。抗原是用脱氧胆酸钠处理胸膜肺炎放线杆菌肉汤培养物后获得的无细胞培养上清液(CFS)。以铁可抑制的转铁蛋白结合脂蛋白TbpB和组成型表达的外膜脂蛋白OmlA为标志物,我们已表明去污剂提取使CFS富含来自外膜(OM)的脂蛋白。用0.05%的脱氧胆酸钠提取可增加CFS中的脂蛋白含量,但不影响OM的完整性。这通过铁可抑制的完整OM转铁蛋白结合蛋白TbpA的缺失得到证明。此外,在用抗细菌碱性磷酸酶和抗Hsp60抗血清进行的免疫印迹分析中确定了提取后CFS中不存在周质和细胞质蛋白,这表明提取过程未导致OM或质膜破裂。将在铁限制条件下生长的2型和9型胸膜肺炎放线杆菌的抗原制剂合并、乳化,并测试它们在猪中提供保护的能力。用来自脱氧胆酸钠提取培养物的CFS免疫的猪产生了强烈的抗体反应,并且在用2型胸膜肺炎放线杆菌攻击后,免疫的猪未表现出或仅表现出轻微的疾病临床症状,并且与对照猪相比肺损伤程度明显更低。

相似文献

1
A novel strategy for protective Actinobacillus pleuropneumoniae subunit vaccines: detergent extraction of cultures induced by iron restriction.一种用于保护性胸膜肺炎放线杆菌亚单位疫苗的新策略:通过铁限制诱导培养物的去污剂提取
Vaccine. 2000 Nov 22;19(7-8):966-75. doi: 10.1016/s0264-410x(00)00212-7.
2
Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.一种抗胸膜肺炎放线杆菌感染的DIVA亚单位疫苗的研发。
Vaccine. 2006 Nov 30;24(49-50):7226-37. doi: 10.1016/j.vaccine.2006.06.047. Epub 2006 Jul 7.
3
Immunoproteomic analyses of outer membrane antigens of Actinobacillus pleuropneumoniae grown under iron-restricted conditions.胸膜肺炎放线杆菌在铁限制条件下生长时外膜抗原的免疫蛋白质组学分析
Vet Microbiol. 2012 Sep 14;159(1-2):187-94. doi: 10.1016/j.vetmic.2012.03.038. Epub 2012 Apr 6.
4
Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and transferrin-binding proteins.用含有Apx毒素和转铁蛋白结合蛋白的疫苗免疫的猪,经9型胸膜肺炎放线杆菌进行支气管内攻毒的效果。
J Vet Med B Infect Dis Vet Public Health. 2001 Feb;48(1):15-20. doi: 10.1046/j.1439-0450.2001.00419.x.
5
Protective effect of the combined vaccine prepared from cell-free-antigen of Actinobacillus pleuropneumoniae serotypes 1, 2 and 5 in pigs.胸膜肺炎放线杆菌1、2和5型无细胞抗原制备的联合疫苗对猪的保护作用。
J Vet Med Sci. 1995 Dec;57(6):1125-8. doi: 10.1292/jvms.57.1125.
6
Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 10 of pigs vaccinated with bacterins consisting of A. pleuropneumoniae serotype 10 grown under NAD-rich and NAD-restricted conditions.用在富含烟酰胺腺嘌呤二核苷酸(NAD)和NAD受限条件下培养的胸膜肺炎放线杆菌10型制备的菌苗对猪进行免疫接种后,用胸膜肺炎放线杆菌10型进行支气管内攻毒的效果。
J Vet Med B Infect Dis Vet Public Health. 2003 Aug;50(6):289-93. doi: 10.1046/j.1439-0450.2003.00676.x.
7
Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.重组ApxIVN在猪抵抗胸膜肺炎放线杆菌感染的免疫保护中发挥积极作用。
Vaccine. 2009 Sep 25;27(42):5816-21. doi: 10.1016/j.vaccine.2009.07.065. Epub 2009 Aug 3.
8
The importance of secreted virulence factors in Actinobacillus pleuropneumoniae bacterin preparation: a comparison.胸膜肺炎放线杆菌疫苗制备中分泌性毒力因子的重要性:一项比较研究。
Vet Microbiol. 1993 Oct;37(1-2):85-100. doi: 10.1016/0378-1135(93)90184-9.
9
AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge.胸膜肺炎放线杆菌的AasP自转运蛋白不能保护猪抵抗同源性攻击。
Vaccine. 2009 Aug 20;27(38):5278-83. doi: 10.1016/j.vaccine.2009.06.047. Epub 2009 Jun 27.
10
Identification of proteins of Propionibacterium acnes for use as vaccine candidates to prevent infection by the pig pathogen Actinobacillus pleuropneumoniae.鉴定痤疮丙酸杆菌的蛋白,作为疫苗候选物预防猪病原体胸膜肺炎放线杆菌感染。
Vaccine. 2013 Oct 25;31(45):5269-75. doi: 10.1016/j.vaccine.2013.08.054. Epub 2013 Sep 16.

引用本文的文献

1
Development and Characterization of a Recombinant galT-galU Protein for Broad-Spectrum Immunoprotection Against Porcine Contagious Pleuropneumonia.用于猪传染性胸膜肺炎广谱免疫保护的重组galT-galU蛋白的研制与特性分析
Int J Mol Sci. 2025 Apr 11;26(8):3634. doi: 10.3390/ijms26083634.
2
Transcriptomics of Haemophilus (Glässerella) parasuis serovar 5 subjected to culture conditions partially mimetic to natural infection for the search of new vaccine antigens.副猪嗜血杆菌(格氏杆菌属)血清型5在部分模拟自然感染的培养条件下的转录组学研究,以寻找新的疫苗抗原。
BMC Vet Res. 2018 Nov 6;14(1):326. doi: 10.1186/s12917-018-1647-1.
3
Identification and characterization of a novel stress-responsive outer membrane protein Lip40 from Actinobacillus pleuropneumoniae.
胸膜肺炎放线杆菌一种新型应激反应外膜蛋白Lip40的鉴定与特性分析
BMC Biotechnol. 2015 Nov 25;15:106. doi: 10.1186/s12896-015-0199-8.
4
Proteomic contributions to our understanding of vaccine and immune responses.蛋白质组学对我们理解疫苗和免疫反应的贡献。
Proteomics Clin Appl. 2015 Dec;9(11-12):972-89. doi: 10.1002/prca.201500054. Epub 2015 Sep 10.
5
A recombinant chimera comprising the R1 and R2 repeat regions of M. hyopneumoniae P97 and the N-terminal region of A. pleuropneumoniae ApxIII elicits immune responses.一种包含猪肺炎支原体P97的R1和R2重复区域以及胸膜肺炎放线杆菌ApxIII N端区域的重组嵌合体可引发免疫反应。
BMC Vet Res. 2014 Feb 18;10:43. doi: 10.1186/1746-6148-10-43.
6
Identification of conserved surface proteins as novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae.鉴定保守表面蛋白作为胸膜肺炎放线杆菌的新型抗原疫苗候选物。
J Microbiol. 2012 Dec;50(6):978-86. doi: 10.1007/s12275-012-2214-2. Epub 2012 Dec 30.
7
Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae.对胸膜肺炎放线杆菌 DIVA 亚单位疫苗的蛋白质组学和免疫蛋白质组学分析。
Proteome Sci. 2011 Apr 20;9(1):23. doi: 10.1186/1477-5956-9-23.
8
Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines.基于与猪转铁蛋白具有亲和力的天然蛋白的猪副猪嗜血杆菌保护性亚单位疫苗的研发与特性分析及其与其他亚单位疫苗和商业疫苗的比较
Clin Vaccine Immunol. 2011 Jan;18(1):50-8. doi: 10.1128/CVI.00314-10. Epub 2010 Oct 6.
9
Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice.评估多组分重组疫苗对胸膜肺炎放线杆菌的小鼠保护作用。
Acta Vet Scand. 2010 Sep 11;52(1):52. doi: 10.1186/1751-0147-52-52.
10
Targeting the porcine immune system--particulate vaccines in the 21st century.靶向猪免疫系统——21世纪的颗粒疫苗
Dev Comp Immunol. 2009 Mar;33(3):394-409. doi: 10.1016/j.dci.2008.07.015. Epub 2008 Sep 2.